Sign In
Buy TMO
$473.95
-8.13 (-1.69%)
At Close: Jun 03, 2026
Thermo Fisher (TMO) Q1 Earnings Beat Estimates, Margins Down
12:47pm, Thursday, 28'th Apr 2022
The robust year-over-year revenue growth across Thermo Fisher's (TMO) Analytical Instruments and the Laboratory Products and Biopharma Services segments appears promising.
Thermo Fisher Scientific's (TMO) CEO Marc Casper on Q1 2022 Results - Earnings Call Transcript
12:19pm, Thursday, 28'th Apr 2022
Thermo Fisher Scientific Inc. (NYSE:TMO ) Q1 2022 Earnings Conference Call April 28, 2022 8:30 AM ET Company Participants Rafael Tejada – Vice President, Investor Relations Marc Casper – Chairman,
Thermo Fisher Scientific (TMO) Surpasses Q1 Earnings and Revenue Estimates
11:15am, Thursday, 28'th Apr 2022 Zacks Investment Research
Thermo Fisher (TMO) delivered earnings and revenue surprises of 17.50% and 11.17%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Thermo Fisher Stock Rises Sharply After a Guidance Boost
11:00am, Thursday, 28'th Apr 2022
The scientific instrument maker says it will be raising prices to offset inflationary pressures.
2 Reasons to Buy Thermo Fisher Scientific, and 1 Reason to Sell
09:55am, Thursday, 28'th Apr 2022 The Motley Fool
The life sciences giant could end up being a victim of its own success.
Thermo Fisher Scientific Stock Jumps As Q1 Earnings Surpass Consensus
09:22am, Thursday, 28'th Apr 2022
Thermo Fisher Scientific Inc (NYSE: TMO) has posted Q1 revenue of $11.82 billion, beating the consensus of $10.63 billion. Organic revenue growth was 3%, acquisitions increased revenue by 18%, and c
Thermo Fisher Scientific (TMO) Surpasses Q1 Earnings and Revenue Estimates
08:17am, Thursday, 28'th Apr 2022
Thermo Fisher (TMO) delivered earnings and revenue surprises of 17.50% and 11.17%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Medical Products Stocks' Earnings on Apr 28: TMO, BIO & More
12:18pm, Wednesday, 27'th Apr 2022
Medical Products companies' results are likely to reflect a rebound in the base business. Let's see how TMO, BIO, LH and RMD fare this time.
Thermo Fisher Scientific: The Healthcare Growth Stock To Choose In A Recession
10:36pm, Tuesday, 12'th Apr 2022
Warning of an economic recession arrived for the first time since 2019. TMO demonstrated its robust growth over the past years and future potential to further expand.
Here's Why You Should Retain Thermo Fisher (TMO) For Now
11:17am, Tuesday, 12'th Apr 2022
Investors are optimistic about Thermo Fisher's (TMO) better-than-expected fourth-quarter results and impressive COVID-19 response-related revenues.
3 Best Life Sciences Stocks to Buy Now
12:25pm, Friday, 08'th Apr 2022
Thinking about digging into immunization stocks? Let's look more broadly, into life sciences stocks.
Thermo Fisher (TMO) Debuts Raman Spectroscopic Analyzer
11:18am, Thursday, 07'th Apr 2022
Thermo Fisher's (TMO) Ramina Process Analyzer allows users to conduct precise in situ Raman measurements in a simple manner with high accuracy.
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 28, 2022
04:05pm, Tuesday, 05'th Apr 2022
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2022 before
A Trio of Stocks Growing Earnings Faster Than Sales
12:24pm, Tuesday, 05'th Apr 2022
Investors may want to consider the following stocks, in my view, since they are growing earnings faster than sales, which may indicate efficient operating activities as profit margins expand along wit
7 Medical Device Stocks to Buy as Covid-19 Fears Fade
07:46am, Tuesday, 05'th Apr 2022
With concerns about Covid-19 fading into the rearview mirror, the normalization of healthcare could benefit these medical device stocks. The post 7 Medical Device Stocks to Buy as Covid-19 Fears Fade
